- Home
- VABK vs LENZ Comparison
VABK vs LENZ Comparison
Compare VABK & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VABK | LENZ |
|---|---|---|
| Founded | 1998 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 231.3M | 198.8M |
| IPO Year | 2013 | 2021 |
Fundamental Metrics
Financial Performance| Metric | VABK | LENZ |
|---|---|---|
| Price | $44.42 | $5.91 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $44.00 |
| AVG Volume (30 Days) | 2.7K | ★ 556.6K |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.39% | N/A |
| EPS Growth | ★ 12.70 | N/A |
| EPS | ★ 0.97 | N/A |
| Revenue | N/A | ★ $19,088,000.00 |
| Revenue This Year | N/A | $50.42 |
| Revenue Next Year | N/A | $197.16 |
| P/E Ratio | $45.43 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $36.60 | $6.29 |
| 52 Week High | $48.58 | $50.19 |
Technical Indicators
Market Signals| Indicator | VABK | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 56.30 | 29.43 |
| Support Level | $37.96 | N/A |
| Resistance Level | $48.58 | $10.42 |
| Average True Range (ATR) | 0.79 | 0.43 |
| MACD | 0.10 | -0.02 |
| Stochastic Oscillator | 81.85 | 3.26 |
Price Performance
Historical ComparisonAbout VABK Virginia National Bankshares Corporation
Virginia National Bankshares Corp is a bank holding company engaged in commercial and retail banking. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts, and other depository services. Its segments include the Bank, VNB Trust and Estate Services, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits, and offering related services to individuals, businesses, and charitable organizations.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.